New Methods in Dry Eye Treatment: Platelet-Rich Plasma
Recent research underscores the variations in preparation techniques for PRP, with formulations like E-PRP (eye-specific PRP) used for ocular surface therapies. Moreover, the increasing application of autologous serum and plasma rich in growth factors for the treatment of DED is substantiated by data indicating their capacity to enhance corneal epithelialization and mitigate DE symptoms. This review highlights the increasing significance of new therapeutic modalities, such as PRP, as essential for controlling DED, offering effective alternatives with improved clinical results.
Authors
- Vahid Hajali (ORCID: https://orcid.org/0000-0003-4096-3031)
- Seyed Amir Miratashi Yazdi (ORCID: https://orcid.org/0000-0003-2274-5727)
- Fatemeh Forouzanfar (ORCID: https://orcid.org/0000-0003-0023-6470)
- Ehsan Saburi (ORCID: https://orcid.org/0000-0002-1679-1068)
- Javad Sadeghi (ORCID: https://orcid.org/0000-0002-3722-9787)
- Kimia Arabi
- Meysan Moghbeli
Institutions
- Mashhad University of Medical Sciences (IR)
- Islamic Azad University, Mashhad (IR)
- Imam Reza Hospital (IR)
Publication Details
- Journal
- Journal of Ocular Pharmacology and Therapeutics
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1177/10807683251390240
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00